Oncology Central

Landmark study raises the bar for interventional oncology


The recent publication of the SIRFLOX trial in the Journal of Clinical Oncology [1] is a landmark for oncologists and radiologists involved in the rapidly advancing field of interventional oncology and liver-directed therapies. The findings are relevant to all oncologists who treat patients with liver metastases.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.